Deferred Tax Assets, Gross in USD of BIOXYTRAN, INC from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Bioxytran, Inc quarterly Deferred Tax Assets, Gross history and change rate from Q4 2018 to Q4 2024.
  • Bioxytran, Inc Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $3.28M, a 19.3% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

BIOXYTRAN, INC Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $3.28M +$529K +19.3% 31 Dec 2024 10-K 03 Apr 2025
Q4 2023 $2.75M +$803K +41.3% 31 Dec 2023 10-K 03 Apr 2025
Q4 2022 $1.94M +$544K +38.9% 31 Dec 2022 10-K/A 13 Jan 2025
Q4 2021 $1.4M +$723K +107% 31 Dec 2021 10-K 31 Mar 2023
Q4 2020 $677K +$503K +287% 31 Dec 2020 10-K 11 Apr 2022
Q4 2019 $175K +$127K +267% 31 Dec 2019 10-K 09 Apr 2021
Q4 2018 $47.6K 31 Dec 2018 10-K 18 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.